{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:35Z","timestamp":1793276975895,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cmi.2024.11.016","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T02:15:06Z","timestamp":1731636906000},"page":"201-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group"],"prefix":"10.1016","volume":"31","author":[{"given":"Susanne","family":"Dudman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjana","family":"Zerja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130mran","family":"Hasano\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"van Welzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Ambra","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"\u00d8verb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Habibovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Bou","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rivero-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.11.016_bib1","series-title":"The global prevalence of hepatitis E virus infection and susceptibility: a systematic review","year":"2010"},{"key":"10.1016\/j.cmi.2024.11.016_bib2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/liv.14468","article-title":"The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cmi.2024.11.016_bib3","series-title":"Waterborne outbreaks of hepatitis E: recognition, investigation and control I","year":"2014"},{"key":"10.1016\/j.cmi.2024.11.016_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cmi.2020.03.039","article-title":"Hepatitis E: an expanding epidemic with a range of complications","volume":"26","author":"Webb","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.016_bib5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.16.30514","article-title":"Hepatitis E and blood donation safety in selected European countries: a shift to screening?","volume":"22","author":"Domanovi\u0107","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2024.11.016_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2024.11.016_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2016.11.016","article-title":"Hepatitis E virus: infection beyond the liver?","volume":"66","author":"Pischke","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2006.09.016","article-title":"Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death","volume":"46","author":"Kumar Acharya","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/v13071329","article-title":"Hepatitis E and pregnancy: an unholy alliance unmasked from Kashmir, India","volume":"13","author":"Khuroo","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2024.11.016_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2022.05.006","article-title":"Chronic hepatitis E: advancing research and patient care","volume":"77","author":"Ma","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid2805.212546","article-title":"Viral hepatitis E outbreaks in refugees and internally displaced populations, sub-Saharan Africa, 2010-2020","volume":"28","author":"Desai","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib12","series-title":"Hepatitis E vaccine: WHO position paper","year":"2015"},{"key":"10.1016\/j.cmi.2024.11.016_bib13","series-title":"Meeting of the strategic advisory group of experts on immunization, March 2024: conclusions and recommendations","year":"2024"},{"key":"10.1016\/j.cmi.2024.11.016_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010969","article-title":"Hepatitis E vaccine-Illuminating the barriers to use","volume":"17","author":"Lynch","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and efficacy of a recombinant hepatitis E vaccine","volume":"356","author":"Shrestha","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.11.016_bib16","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1016\/j.vaccine.2017.05.072","article-title":"A\u00a0phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine","volume":"35","author":"Cao","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib18","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.vaccine.2008.12.061","article-title":"Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.11.016_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1406011","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.11.016_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","article-title":"Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Huang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.11.016_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.vaccine.2022.12.064","article-title":"Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: a randomized, double-blind, controlled, phase 2\/pilot trial","volume":"41","author":"\u00d8verb\u00f8","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cmi.2019.01.015","article-title":"Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial","volume":"25","author":"Chen","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.016_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011661","article-title":"Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan","volume":"18","author":"Nesbitt","year":"2024","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib25","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1016\/S2214-109X(24)00321-8","article-title":"Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan","volume":"12","author":"Nesbitt","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2024.11.016_bib26","doi-asserted-by":"crossref","first-page":"O397","DOI":"10.1111\/1469-0691.12419","article-title":"Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity","volume":"20","author":"Zhang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.016_bib27","article-title":"Long-term antibody persistence after hepatitis E virus infection and vaccination in Dongtai, China","volume":"6","author":"Kmush","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib28","doi-asserted-by":"crossref","first-page":"e1288","DOI":"10.1016\/S2214-109X(24)00192-X","article-title":"Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial","volume":"12","author":"Zaman","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2024.11.016_bib29","doi-asserted-by":"crossref","first-page":"e1300","DOI":"10.1016\/S2214-109X(24)00193-1","article-title":"Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial","volume":"12","author":"Aziz","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2024.11.016_bib30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1080\/22221751.2019.1643260","article-title":"Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model","volume":"8","author":"Li","year":"2019","journal-title":"Emerg Microbe Infect"},{"key":"10.1016\/j.cmi.2024.11.016_bib31","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/hep.25522","article-title":"Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis","volume":"55","author":"Wu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2024.11.016_bib32","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4161\/hv.25814","article-title":"Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults","volume":"9","author":"Wu","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2024.11.016_bib33","unstructured":"Liao X, Li D, Su Y-Y, Wang X, Wu S, Chen Y, et\u00a0al. Safety and immunogenicity of hepatitis E vaccine in compensated liver cirrhosis with chronic hepatitis B. Lancet. DOI:http:\/doi.org\/10.2139\/ssrn.4872352.."},{"key":"10.1016\/j.cmi.2024.11.016_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.32455","article-title":"Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies","volume":"76","author":"He","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2024.11.016_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cytogfr.2021.01.006","article-title":"Hallmarks of aging and immunosenescence: connecting the dots","volume":"59","author":"Rodrigues","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cmi.2024.11.016_bib36","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1038\/s41467-020-17737-w","article-title":"Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans","volume":"11","author":"Wen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2024.11.016_bib37","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S1473-3099(22)00421-2","article-title":"The first reactive vaccination campaign against hepatitis E","volume":"22","author":"Ciglenecki","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12884-020-03116-2","article-title":"Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis","volume":"20","author":"Bigna","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.cmi.2024.11.016_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2185456","article-title":"Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial","volume":"12","author":"Zhong","year":"2023","journal-title":"Emerg Microbe Infect"},{"key":"10.1016\/j.cmi.2024.11.016_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"Electronic address: easloffice@easloffice.eu. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jvh.13754","article-title":"Prognosis of hepatitis E infection in patients with chronic liver disease: a meta-analysis","volume":"30","author":"Qiu","year":"2023","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cmi.2024.11.016_bib42","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib43","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2019.04.006","article-title":"Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years","volume":"37","author":"Yu","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006807","article-title":"Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: a modelling study","volume":"12","author":"Cooper","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib45","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","article-title":"A\u00a0bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates","volume":"23","author":"Li","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib46","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1038\/s41467-018-07200-2","article-title":"Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface","volume":"9","author":"Gouilly","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2024.11.016_bib47","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jhep.2011.01.009","article-title":"Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?","volume":"54","author":"P\u00e9ron","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4254\/wjh.v13.i7.723","article-title":"Hepatitis E virus in professionally exposed: a reason for concern?","volume":"13","author":"Mrzljak","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cmi.2024.11.016_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/hepr.13967","article-title":"Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China","volume":"54","author":"Cui","year":"2024","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cmi.2024.11.016_bib50","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1016\/j.vaccine.2019.08.003","article-title":"Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China","volume":"37","author":"Xia","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib51","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/infdis\/jiae148","article-title":"A\u00a0phase 1, double-blinded, placebo-controlled clinical trial to evaluate the safety and immunogenicity of HEV-239 (Hecolin\u00ae) vaccine in healthy US adults","volume":"230","author":"Kao","year":"2024","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.016_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment","volume":"397","author":"Wouters","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.11.016_bib53","series-title":"One year later: logistics lessons from the world\u2019s first Hepatitis E campaign in South Sudan","year":"2023"},{"key":"10.1016\/j.cmi.2024.11.016_bib54","series-title":"Waterborne outbreaks of hepatitis E: recognition, investigation and control","year":"2014"},{"key":"10.1016\/j.cmi.2024.11.016_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3855\/jidc.6342","article-title":"Concomitant outbreaks of yellow fever and hepatitis E virus in Darfur States, Sudan, 2012","volume":"10","author":"Ahmed","year":"2016","journal-title":"J\u00a0Infect Dev Ctries"},{"key":"10.1016\/j.cmi.2024.11.016_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcv.2015.07.302","article-title":"Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients","volume":"70","author":"Abravanel","year":"2015","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2024.11.016_bib57","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/hep.32745","article-title":"Urine is a viral antigen reservoir in hepatitis E virus infection","volume":"77","author":"Ying","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2024.11.016_bib58","series-title":"The selection and use of essential in\u00a0vitro diagnostics: report of the fourth meeting of the WHO Strategic Advisory Group of Experts on in\u00a0Vitro Diagnostics, 2022 (including the fourth WHO model list of essential in\u00a0vitro diagnostics)","year":"2023"},{"key":"10.1016\/j.cmi.2024.11.016_bib59","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4269\/ajtmh.21-0841","article-title":"Assessment of knowledge, attitude, and practice among Saudi residents regarding hepatitis E virus","volume":"106","author":"Althobaiti","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2024.11.016_bib60","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.11.016_bib62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2217\/fvl.11.86","article-title":"Vaccination of blood donors against hepatitis B is feasible, safe and cost-effective","volume":"6","author":"G\u00e4rtner","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.cmi.2024.11.016_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49674-1","article-title":"A\u00a0systematic review reveals that African children of 15-17 years demonstrate low hepatitis B vaccine seroprotection rates","volume":"13","author":"Muwanda","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2024.11.016_bib64","series-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"key":"10.1016\/j.cmi.2024.11.016_bib65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jceh.2021.12.003","article-title":"Vaccination in chronic liver disease: an update","volume":"12","author":"Alukal","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24005421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24005421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:54:26Z","timestamp":1738450466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24005421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1198743X24005421"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.11.016","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}